Interdisciplinary Concepts in Cardiovascular Health

Volume II: Secondary Risk Factors

Häftad, Engelska, 2016

1 637 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This book provides an introduction to the principles of both cardiovascular epidemiology and molecular pathophysiology; as a unique aspect, it also outlines and discusses the molecular concepts underlying epidemiological observations. This second volume is focused on all aspects concerning “secondary risk factors” in terms of diseases associated with enhanced risk for cardiovascular events. The book promotes the use of interdisciplinary approaches in the field of preventive medicine based on recent advances in molecular and cellular pathophysiology. The book offers a valuable resource for researchers in basic biomedical fields and clinical scientists alike, as well as guidelines for novel avenues of research in both basic pathophysiology and cardiovascular therapy and prevention.

Produktinformation

Utgivningsdatum:2016-08-23
Mått:155 x 235 x 9 mm
Vikt:242 g
Format:Häftad
Språk:Engelska
Antal sidor:137
Förlag:Springer International Publishing AG
ISBN:9783319346441

Utforska kategorier

Mer om författaren

Prof. Dr. (MD, PhD) Ichiro Wakabayashi, Department of Environmental and Preventive Medicine, Hyogo College of Medicine, Japan Prof. Dr. Klaus Groschner, Associate Professor, Department of Pharmaceutical Sciences, Pharmacology and Toxicology, University of Graz, Austria

Recensioner i media

From the reviews: "The book is well organized and written, comprehensive and detailed, and concise. It provides an excellent summary of recent developments in each of the covered topics. It is a recommended tool for any practitioner or researcher who seeks further insight into pathophysiological/molecular mechanisms of cardiovascular disease and epidemiological findings of cardiovascular disorders." (Joaquin Crespo, Doody's Book Reviews, March, 2014)

Innehållsförteckning

Hypertension and vascular dysfunction.- Obesity and diabetes.- Hyper- and dyslipoproteinemias.- Hyperuricemia.- Proteomics towards biomarkers discovery and risk assessment.